NIH-funded research R01 grant

Investigating how RORα influences TH17 cell development and inflammation

Official title: Ligand and transcriptional regulation of the nuclear receptor RORa on TH17 cell development and inflammation

Funded at University of Florida · NIH-11059204 · Data updated 2026-11-12

This study is looking at how a protein called RORα helps shape certain immune cells that can cause inflammation, and by tweaking this protein with special molecules, researchers hope to find new ways to treat autoimmune diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 1, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$618,072
NIH project number5R01DK136298-02
Project IDNIH-11059204 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from autoimmune diseases characterized by chronic inflammation, such as colitis.

Less likely to help

Patients with acute inflammatory conditions or those not affected by autoimmune diseases may not benefit from this research.

What this research studies

This research focuses on understanding the role of RORα, a transcription factor, in the development of TH17 cells, which are involved in immune responses and inflammation. The study aims to explore how RORα regulates gene expression in these cells and how this regulation can affect chronic inflammatory conditions. By using synthetic small molecules to manipulate RORα activity, researchers hope to uncover the mechanisms that lead to either homeostasis or disease. This could provide insights into potential therapeutic targets for autoimmune diseases.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for chronic inflammatory diseases by targeting RORα pathways.

How similar studies have gone: Previous research has shown promising results in understanding the role of nuclear receptors in immune regulation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Solt, Laura a — University of Florida
  • Study coordinator: Solt, Laura a

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.